Exploring Harmaline. To explore a different substance…

Names:
Harmaline · 7-Methoxyharmalan · Harmadine · 3,4-Dihydroharmine · β-Carboline, 3,4-dihydro-7-methoxy-1-methyl · 3,4-Dihydro-7-methoxy-1-methyl-β-carboline
IUPAC names:
7-Methoxy-1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indole
7-Methoxy-1-methyl-4,9-dihydro-3H-β-carboline
ID: 5013 · Formula: C13H14N2O · Molecular weight: 214.263
InChI: InChI=1S/C13H14N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-4,7,15H,5-6H2,1-2H3

McIlhenny, EH; Riba, J; Barbanoj, MJ; Strassman, R; Barker, SA. Methodology for determining major constituents of ayahuasca and their metabolites in blood. Biomed. Chromatogr., 1 Mar 2012, 26 (3), 301–313. 557 kB. http://dx.doi.org/10.1002/bmc.1657

McIlhenny, EH; Riba, J; Barbanoj, MJ; Strassman, R; Barker, SA. Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine. Biomed. Chromatogr., 1 Sep 2011, 25 (9), 970–984. 1.0 MB. http://dx.doi.org/10.1002/bmc.1551

Gambelunghe, C; Aroni, K; Rossi, R; Moretti, L; Bacci, M. Identification of N,N-dimethyltryptamine and β-carbolines in psychotropic ayahuasca beverage. Biomed. Chromatogr., 1 Oct 2008, 22 (10), 1056–1059. 140 kB. http://dx.doi.org/10.1002/bmc.1023

Pires, APS; de Oliveira, CDR; Moura, S; Dõrr, FA; Silva, WAE; Yonamine, M. Gas chromatographic analysis of dimethyltryptamine and β-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage. Phytochem. Anal., 1 Mar 2009, 20 (2), 149–153. 131 kB. http://dx.doi.org/10.1002/pca.1110

McIlhenny, EH; Pipkin, KE; Standish, LJ; Wechkin, HA; Strassman, R; Barker, SA. Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography–electrospray ionization-tandem mass spectrometry. J. Chromatogr. A, 18 Dec 2009, 1216 (51), 8960–8968. 450 kB. http://dx.doi.org/10.1016/j.chroma.2009.10.088

Meyer, MR; Caspar, A; Brandt, SD; Maurer, HH. A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches. Anal. Bioanal. Chem., 1 Jan 2014, 406 (1), 225–237. 457 kB. http://dx.doi.org/10.1007/s00216-013-7425-9

McKenna, DJ. Monoamine oxidsase inhibitors in Amazonian hallucinogenic plants: Ethnobotanical, phytochemical, and pharmacological investigations. Ph. D. Thesis, University of British Columbia, BC, Canada, 26 Apr 1984. 12.2 MB.

Glennon, RA; Dukat, M; Grella, B; Hong, S; Costantino, L; Teitler, M; Smith, C; Egan, C; Davis, K; Mattson, MV. Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors. Drug Alcohol Depend., 1 Aug 2000, 60 (2), 121–132. 276 kB. http://dx.doi.org/10.1016/S0376-8716(99)00148-9

Shulgin, AT. Ayahuasca and MAO inhibitors. Ask Dr. Shulgin Online, Center for Cognitive Liberty & Ethics, 12 Feb 2002.

Naranjo, C. Psychotherapeutic Possibilities of New Fantasy-Enhancing Drugs. Clin. Toxicol., 1 Jan 1969, 2 (2), 209–224. 855 kB. http://dx.doi.org/10.3109/15563656908990930

Samoylenko, V; Rahman, MM; Tekwani, BL; Tripathi, LM; Wang, Y; Khan, SI; Khan, IA; Miller, LS; Joshi, VC; Muhammad, I. Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson’s disease. J. Ethnopharmacol., 3 Feb 2010, 127 (2), 357–367. 357 kB. http://dx.doi.org/10.1016/j.jep.2009.10.030

Shulgin, AT. Profiles of psychedelic drugs. 4. Harmaline. J. Psychedelic Drugs, 1 Jan 1977, 9 (1), 79–80. 1.1 MB. http://dx.doi.org/10.1080/02791072.1977.10472029

7-MeO-DHβC
8-MeO-DHβC
Harmalan
Harminol
Harmine
7-MeO-THH · Tetrahydroharmine
6-Methoxyharmalan
5-Methoxyharmalan
8-Methoxyharmalan
7-MeO-DHβC
8-MeO-DHβC
Harmalan
Harminol
Harmine
7-MeO-THH · Tetrahydroharmine
6-Methoxyharmalan
5-Methoxyharmalan
8-Methoxyharmalan
17 November 2017 · Creative Commons BY-NC-SA ·